ACADIA Pharmaceuticals Inc.
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership729,836 shares
Latest Disclosed Value $ 16,246,149
D. E. Shaw & Co., Inc. ownership in ACAD / ACADIA Pharmaceuticals Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 729,836 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $16,246,149 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,026,785 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -28.92% during the quarter. The current value of the position is $15,640,385 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (ACAD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ACAD / ACADIA Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 729,836 -296,949 -28.92 16,246 -40.76 0.0098
2026-02-17 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,026,785 -534,376 -34.23 27,425 -17.68 0.0150
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,561,161 -403,360 -20.53 33,315 -21.38 0.0188
2025-08-14 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,964,521 -384,899 -16.38 42,375 8.59 0.0300
2025-05-15 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,349,420 -891,986 -27.52 39,024 -34.39 0.0347
2025-02-14 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,241,406 -263,551 -7.52 59,480 10.34 0.0436
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,504,957 570,031 19.42 53,906 13.03 0.0463
2024-08-14 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,934,926 292,906 11.09 47,693 -2.37 0.0446
2024-05-15 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,642,020 -1,112,578 -29.63 48,851 -58.45 0.0418
2024-02-14 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,754,598 -1,034,400 -21.60 117,556 17.79 0.1027
2023-11-14 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,788,998 -474,080 -9.01 99,803 -20.82 0.1042
2023-08-14 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 5,263,078 362,496 7.40 126,051 36.67 0.1288
2023-05-15 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,900,582 681,183 16.14 92,229 37.30 0.0987
2023-02-14 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,219,399 -492,781 -10.46 67,173 -12.87 0.0742
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,712,180 25,515 0.54 77,092 16.74 0.0921
2022-08-15 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,686,665 139,702 3.07 66,035 -40.04 0.0774
2022-05-16 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,546,963 19,760 0.44 110,128 4.22 0.1031
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,527,203 -1,043,329 -18.73 105,665 14.20 0.0876
2021-11-15 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 5,570,532 805,467 16.90 92,527 -20.39 0.0835
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,765,065 2,409,857 102.32 116,220 91.26 0.1003
2021-05-17 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,355,208 112,408 5.01 60,764 -49.32 0.0587
2021-02-16 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,242,800 -21,713 -0.96 119,900 28.36 0.1072
2020-11-16 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,264,513 116,305 5.41 93,411 -10.29 0.0956
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,148,208 858,079 66.51 104,124 91.03 0.1240
2020-05-15 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,290,129 -86,965 -6.32 54,508 -7.48 0.0850
2020-02-14 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,377,094 -895,290 -39.40 58,912 -27.97 0.0674
2019-11-14 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,272,384 370,534 19.48 81,783 60.88 0.1007
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,901,850 461,869 32.07 50,836 31.48 0.0634
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,439,981 1,290,639 864.22 38,663 1,500.95 0.0500
2019-02-14 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 149,342 149,342 2,415 0.0033
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -56,267 -100.00 0 -100.00
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 56,267 56,267 859 0.0011
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -18,429 -100.00 0 -100.00
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,429 18,429 694 0.0011
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -6,358 -100.00 0 -100.00
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 6,358 -45,088 -87.64 219 -85.24 0.0004
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 51,446 -54,437 -51.41 1,484 -55.94 0.0025
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 105,883 98,063 1,254.00 3,368 1,225.98 0.0059
2016-08-15 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 7,820 -20,746 -72.62 254 -68.21 0.0005
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 28,566 -36,184 -55.88 799 -65.38 0.0014
2016-02-16 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 64,750 17,974 38.43 2,308 49.19 0.0034
2015-11-16 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 46,776 1,445 3.19 1,547 -18.49 0.0023
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 45,331 15,882 53.93 1,898 97.71 0.0028
2015-05-15 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 29,449 -144,752 -83.09 960 -82.64 0.0015
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 174,201 38,562 28.43 5,531 64.71 0.0071
2014-11-14 2014-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 135,639 8,424 6.62 3,358 16.84 0.0043
2014-08-14 2014-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 127,215 64,251 102.04 2,874 87.60 0.0039
2014-05-15 2014-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 62,964 -7,753 -10.96 1,532 -13.30 0.0022
2014-02-14 2013-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 70,717 30,913 77.66 1,767 61.67 0.0024
2013-11-20 2013-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 39,804 -57,838 -59.23 1,093 -38.32 0.0017
2013-11-14 2013-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 39,804 1,093
2013-08-14 2013-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 97,642 97,642 1,772 0.0033
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM Call 40,000 0.00 1,154 -9.28 n/a n/a n/a
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM Call 40,000 0.00 1,272 -2.00 n/a n/a n/a
2016-08-15 2016-06-30 13F ACADIA PHARMACEUTICALS COM Call 40,000 0.00 1,298 16.10 n/a n/a n/a
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICALS COM Call 40,000 1,118 n/a n/a n/a
2015-05-15 2015-03-31 13F ACADIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM Call 43,800 0.00 1,391 28.32 n/a n/a n/a
2014-11-14 2014-09-30 13F ACADIA PHARMACEUTICALS COM Call 43,800 -12.40 1,084 -4.07 n/a n/a n/a
2014-08-14 2014-06-30 13F ACADIA PHARMACEUTICALS COM Call 50,000 -23.08 1,130 -28.53 n/a n/a n/a
2014-05-15 2014-03-31 13F ACADIA PHARMACEUTICALS COM Call 65,000 -48.78 1,581 -50.14 n/a n/a n/a
2014-02-14 2013-12-31 13F ACADIA PHARMACEUTICALS COM Call 126,900 0.00 3,171 -9.04 n/a n/a n/a
2013-11-20 2013-09-30 13F/A ACADIA PHARMACEUTICALS COM Call 126,900 69.20 3,486 156.14 n/a n/a n/a
2013-11-14 2013-09-30 13F ACADIA PHARMACEUTICALS COM Call 126,900 3,486 n/a n/a n/a
2013-08-14 2013-06-30 13F ACADIA PHARMACEUTICALS COM Call 75,000 1,361 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F ACADIA PHARMACEUTICALS COM Put 47,000 0.00 1,415 -20.06 n/a n/a n/a
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM Put 47,000 0.00 1,770 35.01 n/a n/a n/a
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM Put 47,000 -42.05 1,311 -52.98 n/a n/a n/a
2017-05-15 2017-03-31 13F ACADIA PHARMACEUTICALS COM Put 81,100 -19.78 2,788 -4.39 n/a n/a n/a
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM Put 101,100 44.43 2,916 30.94 n/a n/a n/a
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM Put 70,000 133.33 2,227 128.64 n/a n/a n/a
2016-08-15 2016-06-30 13F ACADIA PHARMACEUTICALS COM Put 30,000 50.00 974 74.24 n/a n/a n/a
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICALS COM Put 20,000 559 n/a n/a n/a
2015-05-15 2015-03-31 13F ACADIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM Put 134,100 0.00 4,258 28.25 n/a n/a n/a
2014-11-14 2014-09-30 13F ACADIA PHARMACEUTICALS COM Put 134,100 0.00 3,320 9.61 n/a n/a n/a
2014-08-14 2014-06-30 13F ACADIA PHARMACEUTICALS COM Put 134,100 -1.69 3,029 -8.74 n/a n/a n/a
2014-05-15 2014-03-31 13F ACADIA PHARMACEUTICALS COM Put 136,400 -23.80 3,319 -25.80 n/a n/a n/a
2014-02-14 2013-12-31 13F ACADIA PHARMACEUTICALS COM Put 179,000 -1.97 4,473 -10.83 n/a n/a n/a
2013-11-20 2013-09-30 13F/A ACADIA PHARMACEUTICALS COM Put 182,600 14.12 5,016 72.73 n/a n/a n/a
2013-11-14 2013-09-30 13F ACADIA PHARMACEUTICALS COM Put 182,600 5,016 n/a n/a n/a
2013-08-14 2013-06-30 13F ACADIA PHARMACEUTICALS COM Put 160,000 2,904 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.